{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:10:59Z","timestamp":1789423859308,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd007259","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T00:00:00Z","timestamp":1424131200000}}],"reference-count":34,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007259.pub2","type":"journal-article","created":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T00:35:54Z","timestamp":1424133354000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors"],"prefix":"10.1002","volume":"2021","author":[{"given":"Nerida L","family":"Klupp","sequence":"additional","affiliation":[{"name":"National Institute of Complementary Medicine; University of Western Sydney; Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Chang","sequence":"additional","affiliation":[{"name":"National Institute of Complementary Medicine; University of Western Sydney; Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Hawke","sequence":"additional","affiliation":[{"name":"School of Health Sciences, Faculty of Health and Medicine; The University of Newcastle; Ourimbah Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hosen","family":"Kiat","sequence":"additional","affiliation":[{"name":"The Australian School of Advanced Medicine, Macquarie University; Cardiac Health Institute; Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Cao","sequence":"additional","affiliation":[{"name":"Centre for Evidence-Based Chinese Medicine; Beijing University of Chinese Medicine; Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne J","family":"Grant","sequence":"additional","affiliation":[{"name":"National Institute of Complementary Medicine; University of Western Sydney; Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Bensoussan","sequence":"additional","affiliation":[{"name":"National Institute of Complementary Medicine; University of Western Sydney; Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,2,17]]},"reference":[{"key":"10.1002\/14651858.CD007259.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1017\/S0007114511003795","article-title":"Study of potential cardioprotective effects of Ganoderma lucidum (Lingzhi): results of a controlled human intervention trial","volume":"107","author":"Chu","year":"2012","journal-title":"British Journal of Nutrition"},{"key":"10.1002\/14651858.CD007259.pub2-BIB0002|cit2","first-page":"33","article-title":"A phase I\/II study of Ling Zhi mushroom Ganoderma lucidum (W.Curt.:Fr.) Lloyd (Aphyllophoromycetideae) extract in patients with type II diabetes mellitus","volume":"6","author":"Gao","year":"2004","journal-title":"International Journal of Medicinal Mushrooms"},{"issue":"4","key":"10.1002\/14651858.CD007259.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1615\/IntJMedMushr.v6.i4.30","article-title":"A phase I\/II study of Ling Zhi mushroom Ganoderma lucidum (W.Curt.:Fr.) Lloyd (Aphyllophoromycetideae) extract in patients with coronary heart disease","volume":"6","author":"Gao","year":"2004","journal-title":"International Journal of Medicinal Mushrooms"},{"key":"10.1002\/14651858.CD007259.pub2-BIB0004|cit4","unstructured":"Klupp NL Bensoussan A Kiat H Hawke F Chang D Ganoderma lucidum for hyperglycaemia in persons with metabolic syndrome Unpublished raw data 2014"},{"key":"10.1002\/14651858.CD007259.pub2-BIB0005|cit5","first-page":"54","article-title":"Ganoderma lucidum on metabolic control in type 2 diabetes subjects - a double blinded placebo control study","volume":"19","author":"Wang","year":"2008","journal-title":"Journal of Internal Medicine of Taiwan"},{"key":"10.1002\/14651858.CD007259.pub2-BIB0006|cit6","first-page":"131","volume-title":"Microcirculatory approach to Asian traditional medicine","author":"Jin","year":"1996"},{"key":"10.1002\/14651858.CD007259.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1079\/BJN20041039","article-title":"Ganoderma lucidum ('Lingshi'), a Chinese medicinal mushroom: biomarker responses in a controlled human supplementation study","volume":"91","author":"Wachtel-Galor","year":"2004","journal-title":"British Journal of Nutrition"},{"key":"10.1002\/14651858.CD007259.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2471\/BLT.08.057885","article-title":"Cardiovascular risk factor trends and potential for reducing coronary heart disease mortality in the United States of America","volume":"88","author":"Capewell","year":"2010","journal-title":"Bulletin of the World Health Organisation"},{"key":"10.1002\/14651858.CD007259.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1615\/IntJMedMushrooms.v1.i2.30","article-title":"Ganoderma lucidum (Curt.:Fr.) P. Karst. (Aphyllophoromycetideae): a mushrooming medicinal mushroom","volume":"1","author":"Chang","year":"1999","journal-title":"International Journal of Medicinal Mushrooms"},{"key":"10.1002\/14651858.CD007259.pub2-BIB0010|cit10","volume-title":"Mushrooms: Cultivation, nutritional value, medicinal effect and environmental impact","author":"Miles","year":"2000"},{"key":"10.1002\/14651858.CD007259.pub2-BIB0011|cit11","first-page":"883","volume-title":"Chinese medical herbology and pharmacology","author":"Chen","year":"2004"},{"key":"10.1002\/14651858.CD007259.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.phymed.2011.03.011","article-title":"Ganoderol B: a potent \u03b1-glucosidase inhibitor isolated from the fruiting body of Ganoderma lucidum","volume":"18","author":"Fatmawati","year":"2011","journal-title":"Phytomedicine"},{"key":"10.1002\/14651858.CD007259.pub2-BIB0013|cit13","unstructured":"Higgins JP Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD007259.pub2-BIB0014|cit14","first-page":"339","article-title":"Isolation and hypoglycemic activity of ganoderans A and B, glycans of Ganoderma lucidum fruit body","volume":"4","author":"Hikino","journal-title":"Planta Medica"},{"issue":"3","key":"10.1002\/14651858.CD007259.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMp068177","article-title":"Obesity and diabetes in the developing world - a growing challenge","volume":"356","author":"Hossain","year":"2007","journal-title":"New England Journal of Medicine"},{"issue":"1-2","key":"10.1002\/14651858.CD007259.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1570-0232(04)00678-6","article-title":"Chromatographic and electrophoretic methods for Lingzhi pharmacologically active components","volume":"812","author":"Huie","year":"2004","journal-title":"Journal of Chromatography. B, Analytical Techniques in the Biomedical and Life Sciences"},{"issue":"10","key":"10.1002\/14651858.CD007259.pub2-BIB0017|cit17","first-page":"942","article-title":"Studies on Ganoderma lucidum. I. Efficacy against hypertension and side effects","volume":"105","author":"Kanmatsuse","year":"1985","journal-title":"Journal of the Pharmaceutical Society of Japan"},{"issue":"2","key":"10.1002\/14651858.CD007259.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1248\/cpb.37.531","article-title":"Ganoderic acid and its derivatives as cholesterol synthesis inhibitors","volume":"37","author":"Komoda","year":"1989","journal-title":"Chemical and Pharmaceutical Bulletin"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007259.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/tcm.10065","article-title":"Anti-peroxidative, anti-inflammatory, and antimutagenic activities of ethanol extract of the mycelium of Ganoderma lucidum occurring in South India","volume":"23","author":"Lakshmi","year":"2003","journal-title":"Teratogenesis, carcinogenesis, and mutagenesis"},{"issue":"5","key":"10.1002\/14651858.CD007259.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1248\/cpb.38.1359","article-title":"Cardiovascular effects of mycelium extract of Ganoderma lucidum: Inhibition of sympathetic outflow as a mechanism of its hypotensive action","volume":"38","author":"Lee","year":"1990","journal-title":"Chemical and Pharmaceutical Bulletin"},{"key":"10.1002\/14651858.CD007259.pub2-BIB0021|cit21","first-page":"825","volume-title":"Botanical medicines: The desk reference for major herbal supplements","author":"McKenna","year":"2002"},{"issue":"7","key":"10.1002\/14651858.CD007259.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1248\/cpb.34.3025","article-title":"Angiotensin converting enzyme-inhibitory triterpenes from Ganoderma lucidum","volume":"34","author":"Morigawa","year":"1986","journal-title":"Chemical and Pharmaceutical Bulletin"},{"key":"10.1002\/14651858.CD007259.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals for the Centers for Disease Control and Prevention and the American Heart Association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD007259.pub2-BIB0024|cit24","unstructured":"Review Manager (RevMan) The Nordic Cochrane Centre, The Cochrane Collaboration 2014"},{"issue":"7","key":"10.1002\/14651858.CD007259.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1248\/cpb.33.3012","article-title":"Isolation of an inhibitor of platelet aggregation from a fungus, Ganoderma lucidum","volume":"33","author":"Shimizu","year":"1985","journal-title":"Pharmaceutical Bulletin"},{"issue":"4","key":"10.1002\/14651858.CD007259.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/BF02887938","article-title":"Experimental and clinical studies on inhibitory effect of Ganoderma lucidum on platelet aggregation","volume":"10","author":"Tao","year":"1990","journal-title":"Journal of Tongji Medical University"},{"key":"10.1002\/14651858.CD007259.pub2-BIB0027|cit27","volume-title":"Mushroom Biology and Mushroom Products","author":"Teow","year":"1996"},{"issue":"12","key":"10.1002\/14651858.CD007259.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1016\/S0031-9422(00)83748-6","article-title":"Glycan structures of ganoderans B and C, hypoglycemic glycans of Ganoderma lucidum fruit bodies","volume":"25","author":"Tomoda","year":"1986","journal-title":"Phytochemistry"},{"issue":"2","key":"10.1002\/14651858.CD007259.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1079\/BJN20041039","article-title":"Ganoderma lucidum ('Lingzhi'), a Chinese medicinal mushroom: biomarker responses in a controlled human supplementation","volume":"91","author":"Wachtel-Galor","year":"2004","journal-title":"British Journal of Nutrition"},{"issue":"1","key":"10.1002\/14651858.CD007259.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/09637480310001642510","article-title":"Ganoderma lucidum ('Lingzhi'): acute and short term biomarker response to supplementation","volume":"55","author":"Wachtel-Galor","year":"2004","journal-title":"International Journal of Food Sciences and Nutrition"},{"key":"10.1002\/14651858.CD007259.pub2-BIB0031|cit31","volume-title":"Global atlas on cardiovascular disease prevention and control","author":"World Stroke Organization: Mendis","year":"2011"},{"key":"10.1002\/14651858.CD007259.pub2-BIB0032|cit32","volume-title":"Reishi mushroom: Herb of spiritual potency and medical wonder","year":"1990"},{"issue":"6","key":"10.1002\/14651858.CD007259.pub2-BIB0033|cit33","first-page":"872","article-title":"Hypolipidemic effect of exo- and endo-biopolymers produced from submerged mycelial culture of Ganoderma lucidum in rats","volume":"12","author":"Yang","year":"2002","journal-title":"Journal of Microbiology and Biotechnology"},{"issue":"2","key":"10.1002\/14651858.CD007259.pub2-BIB0034|cit34","first-page":"191","article-title":"Hypoglycemic effect of Ganoderma lucidum polysaccharides","volume":"25","author":"Zhang","year":"2004","journal-title":"Acta Pharmacologica Sinica"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD007259.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T07:03:05Z","timestamp":1706684585000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007259.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Heart Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,2,17]]},"references-count":34,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007259.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,17]]}}}